Overview
Anticancer Peptides, also known as cytolytic Peptides, are short sequences of amino acids that are found naturally in the human body and possess the ability to inhibit the growth of cancer cells by disrupting the cell membrane of malignant cells. These Peptides have the potential to replace traditional chemotherapy and radiation treatments, as they are able to specifically target cancer cells while leaving healthy cells unharmed. A number of different anticancer Peptides have been developed, and they are being researched and tested in clinical trials, as they offer a promising approach to cancer treatment.
Research published in this journal
No peer-reviewed research on this exact topic has been published in Peptides yet. Browse the journal →